Samsung BioLogics is CDMO headquartered in Incheon, South Korea.
As a joint venture between Samsung affiliate companies and Quintiles Transnational Corp., Samsung BioLogics aims to become a global leader in the biopharmaceutical manufacturing industry. Our biologics business builds on principles of our past acheivements and brings our technological leadership to the biologics sector.
With Samsung's quality, technology, and innovation, Samsung BioLogics will establish a new global standard for best practices within biopharmaceutical manufacturing.
We are committed to excellence in the development and manufacturing of bio-healthcare products and our state-of-the-art facilities are fully compliant with global healthcare regulations and Current Good Manufacturing Practice standards.